CTX-712

Overview

CTX-712 is an oral CLK inhibitor being studied for use in several different cancers.

SparkCures ID 548
Generic Name CTX-712
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.